Bcal Diagnostics
(ASX) BDX
Bcal Diagnostics Financials at a Glance
Market Cap
$33.92M
Revenue (TTM)
$3.88M
Net Income (TTM)
$15.15M
EPS (TTM)
$-0.02
P/E Ratio
-4.69
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$0.09
Volume
50,045
Open
$0.09
Price
$0.09
Volume
50,045
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.05 - $0.15
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$0.09
Volume
50,045
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.05 - $0.15
BDX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bcal Diagnostics
Industry
Biotechnology
Sector
Health CareCEO
Shane Ryan
Website
www.bcaldiagnostics.comHeadquarters
Sydney, NSW 2000, AU
BDX Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
-6%
Net Income Margin
-5%
Return on Equity
-122%
Return on Capital
-1%
Return on Assets
-100%
Earnings Yield
-21.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$33.92M
Shares Outstanding
368.68M
Volume
50.05K
Short Interest
0.00%
Avg. Volume
247.99K
Financials (TTM)
Gross Profit
$21.64K
Operating Income
$9.96M
EBITDA
$6.19M
Operating Cash Flow
$6.14M
Capital Expenditure
$787.67K
Free Cash Flow
$6.92M
Cash & ST Invst.
$4.52M
Total Debt
$2.38M
Bcal Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$42.62K
-97.7%
Gross Profit
$349.25K
-118.8%
Gross Margin
-8.19%
N/A
Market Cap
$33.92M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$3.92M
-62.8%
EBITDA
$4.63M
-17.3%
Quarterly Fundamentals
Net Cash
$445.76K
-112.7%
Accounts Receivable
$1.34M
+2.4%
Inventory
$0.00
N/A
Long Term Debt
$3.31M
+190.9%
Short Term Debt
$464.35K
+27.6%
Return on Assets
-99.81%
N/A
Return on Invested Capital
-1.34%
N/A
Free Cash Flow
$2.95M
-190.3%
Operating Cash Flow
$2.50M
-181.5%